4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001635088-26-000034
CEO gave up 358,510 shares (to pay taxes)
- CEO acquired 97,319 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gline Matthew · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-30 | Exercise or conversion : show line 1 in the form | +97,319 | 17,384,400 | D | ||
| 2026-03-30 | Shares withheld for taxes : show line 2 in the form | −53,826 | $26.41 | $1,421,545 | 17,330,574 | D |
| 2026-03-31 | Shares withheld for taxes : show line 3 in the form | −304,684 | $27.70 | $8,439,747 | 17,025,890 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-30 | Exercise or conversion : show line 4 in the form Capped Value Appreciation Rights | −2,178,150 | $11.50 | $25,048,725 | 0 | D |
Loading xslF345X06/wk-form4_1775085629.xml…